Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifloxacin 0.6% BID vs Vehicle in Bacterial Conjunctivitis
NCT00972777Phase 3Completed
- Sponsor
- Bausch + Lomb
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of besifloxacin in bacterial conjunctivitis (BC), sponsored by Bausch + Lomb. Started Oct 2009; status: completed.
02
Drugs
besifloxacin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00972777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972777.